Micro Emerging Active

Heartflow's strong revenue performance

New narrative with limited coverage — still forming.

Score 0.3

Velocity ▲ 0.0

Articles 1

Sources 1

Sentiment Timeline

Event Timeline

Aug 17, 2026 Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand Neutral

Hypotheses

Pending Due: Nov. 15, 2026

Heartflow will report gross margin expansion of at least 200 basis points in Q2 2024 compared to Q2 2023, reflecting operational leverage from strong revenue performance and improved product mix.

Pending Due: Dec. 15, 2026

HTFL stock will maintain a price above $25 per share for 60+ consecutive trading days following the 46% rally, indicating sustainable institutional investor confidence in revenue trajectory.

Pending Due: Nov. 15, 2026

Heartflow's revenue growth will sustain above 30% YoY through Q2 2024, driven by increased adoption of its AI-powered cardiac imaging platform in enterprise healthcare systems.